Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    System revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:23:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the record history, and the v3.4.2 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:28:41.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the study record history. Removed the government funding notice and the older Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:38:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added, and the record history shows a version update from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-03T23:41:18.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The update adds a glossary toggle, introduces green/red highlights for additions and deletions, and a new Revision: v3.4.0 banner; no changes to study data or results are observed.
    Difference
    1%
    Check dated 2026-01-27T21:26:52.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A new entry Revision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure and the older Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T08:19:18.000Z thumbnail image

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.